$5.07
-$0.13
(-2.50%)
Quote as of 3:59 PM EST on 02/10/12
Celldex Therapeutics, Inc.
NASDAQ:CLDX
Extended Hours:
$5.07
$0.00
(0.00%)
Quote as of 5:15 PM EST on 02/10/12 (NASDAQ)
|
$5.07
-$0.13
(-2.50%)
|
|
| Today's Open | $5.13 |
|---|---|
| Previous Close | $5.20 |
| Daily Range | $4.94 - $5.17 |
| 52-Week Range | $2.05 - $5.66 |
| Market Cap | $223.83M |
| P/E Ratio | -37.14 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 404,734 |
| Average Daily Volume | 609,756 |
| Current FY EPS | -$1.10 |
CLDX Information
| Description |
|---|
| A biopharmaceutical company engaged in the discovery, development and commercialization of products that harness the human immune response to prevent and treat disease. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
5 Oncology Drugs Available for Partnering
Interview: ImmunoCellular Therapeutics' CEO on What's New in Cancer Therapy
Major FDA Approval Could Pave the Way for These 5 Biotechs
Ipilimumab Approval Highlights Active Immunotherapy Renaissance
To Partner or Not to Partner: That is the Question
Is Celldex Poised for a Comeback?
Battered but Unbroken Biotechs
Friday Options Brief: USO, MWW, AMCC & CLDX
Celldex: Can Anything Halt It's Slide?
